Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by mollevi
Group name EquipeMY
Item Type Journal Article
Title The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei
Creator Carr et al.
Author Norman J. Carr
Author Robert F. Bradley
Author Peggy Dartigues
Author Roger M. Feakins
Author Kim R. Geisinger
Author Xianyong Gui
Author Sylvie Isaac
Author Massimo Milione
Author Joseph Misdraji
Author Reetesh K. Pai
Author Manuel Rodriguez-Justo
Author Leslie H. Sobin
Author Marie-Louise F. van Velthuysen
Author Rhonda K. Yantiss
Abstract The vermiform appendix is the primary site of several distinctive benign and malignant neoplasms. Some can produce the clinical syndrome of pseudomyxoma peritonei (PMP). A consensus on their terminology was reached by an international panel of pathologists and clinicians working under the auspices of the Peritoneal Surface Oncology Group International (PSOGI), and this review discusses the application of the PSOGI classification to routine reporting. We discuss diagnosis and differential diagnosis together with implications for patient management, covering low-grade appendiceal mucinous neoplasms, high-grade appendiceal mucinous neoplasms, serrated polyps, adenomas and adenocarcinomas. We do not cover goblet cell tumours or neuroendocrine neoplasms in this paper.
Publication Histopathology
Volume 71
Issue 6
Pages 847-858
Date Dec 2017
Journal Abbr Histopathology
Language eng
DOI 10.1111/his.13324
ISSN 1365-2559
Library Catalog PubMed
Extra PMID: 28746986
Tags Adenocarcinoma, Adenoma, Appendiceal Neoplasms, Appendix, Diagnosis, Differential, Humans, original, Peritoneal Neoplasms, Peritoneum, Polyps
Date Added 2018/11/13 - 17:25:51
Date Modified 2019/05/21 - 13:24:46


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés